Medical Cannabis Research
Cannabidiol (CBD) as an Anti-Arrhythmic – the Role of the CB1 Receptors
Cannabidiol (CBD) has been shown to be anti-arrhythmic (Walsh et al, 2010) and tissue sparing (Durst et al, 2007) in an in vivo rat model of coronary artery occlusion (CAO), although the receptors through which this occurs have yet to be identified. read more…
The Endocannabinoid System and Memory Disorders
THC and Memory: The most recent Journal of Cognitive Neuroscience reports on a study out of the University Medical Center in Utrecht, the Netherlands. Deficits in memory function are an incapacitating aspect of various psychiatric and neurological disorders. Animal studies have recently provided strong evidence for involvement of the endocannabinoid (eCB) system in memory function. The Abstract is posted here. read more…
Hazekamp & Grotenhermen: Review on clinical studies with cannabis and cannabinoids
To date, a large number of controlled clinical trials have been done evaluating the therapeutic applications of cannabis and cannabis-based preparations. This current review reports on the more recent clinical data available.
Published in Cannabinoids 2010;5(Special Issue): 1-21
Institute Biology Leiden, Leiden University, The Netherlands
Henquet & Cooper: Does Cannabidiol Protect Against the Negative Effects of THC?
A recent study by Morgan and colleagues found that cannabidiol attenuates the acute cognitive effects of THC. This is of interest as THC has been associated with the detrimental effects of cannabis on mental health in at-risk users, and the potency of cannabis is increasing.
Henquet: Does Cannabidiol Protect Against Negative Effects of THC
Izzo: Non-Psychotropic Plant Cannabinoids
The plant Cannabis sativa produces over 421 chemical compounds, including about 80 terpeno-phenol compounds named phytocannabinoids that have not been detected in any other plant. Here, we provide an overview of the recent pharmacological advances, novel mechanisms of action, and potential therapeutic applications of such non-psychotropic plant-derived cannabinoids.
Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb
SCC Hears McAllister On Cannabis Cancer Research
Sean McAllister, PhD, who has been studying the anti-cancer effects of cannabinoids in the laboratory (on a grant from NIH and with a license from the DEA). The occasion was the winter meeting of the Society of Cannabis Clinicians.”That’s a very good question,” McAllister would say…and provide the answer, and tie it back into his main thread. read more…
Project CBD
Project CBD is a non-profit educational service dedicated to promoting and publicizing research into the medical utility of cannabidiol (CBD) and other components of the Cannabis plant. It was conceived by two journalists who have been covering the medical cannabis movement / industry in the pages of O’Shaughnessy’s Journal of Cannabis in Clinical Practice. read more…